en · de · es · pt
aod-9604-notes.peptides6608.com › Wiki › Regulatory And Analytical Context — 2026 Update

Regulatory And Analytical Context — 2026 Update

By Editorial Desk · published 2026-03-23 · last reviewed 2026-05-08 · Wiki

The short version of regulatory status fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-05-08. Anything still debated is marked as such rather than presented as settled.

Regulatory and Analytical Context

Detection and characterization of AOD-9604 in research and anti-doping settings typically rely on mass spectrometry coupled with liquid chromatography. These methods can identify the peptide by its mass and fragmentation pattern. Immunoassays may also be used in some screening contexts, but they can cross-react with related peptides. Because the molecule is small and may be present at low concentrations, sample preparation and method validation are important. Confirmatory analysis usually requires comparison with a certified reference standard.

In laboratory settings, AOD-9604 is commonly supplied as a lyophilized powder and stored cold to limit degradation. Reconstituted solutions are typically kept refrigerated or frozen, depending on the buffer and concentration, and protected from repeated freeze-thaw cycles. Stability can be influenced by pH, temperature, and the presence of proteases. Purity is usually assessed by high-performance liquid chromatography and mass spectrometry. These practices support reproducibility, but they do not imply safety or efficacy for any human use.

Measurement and Storage Practices

Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.

Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.

Aod-9604 at a glance

PropertyValueNotes
Regulatory statusNot approved as a medicineStatus varies by country; prohibited in sport.
Common storage temperature2–8 °C for lyophilized powderProtect from light and moisture; follow supplier instructions.
Typical analytical methodLC-MS/MSUsed for identification and quantification in biological samples.
Purity assessmentHPLC and mass spectrometryReverse-phase HPLC is common for peptide purity.
Common synonymsAOD9604; hGH 176-191 fragmentNaming conventions differ across studies.

Identity and Research Origin

Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.

AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.

Related pages on this site

Handling, Analysis, and Quality Control

Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.

AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.

Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.

Background and Development History

Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.

AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.

Laboratory studies have reported that AOD9604 can increase lipolysis and reduce lipid accumulation in fat cells. The precise molecular target remains uncertain, and the compound does not appear to activate the growth hormone receptor in the same way as full-length hGH. Proposed mechanisms include effects on beta-adrenergic signaling and enzymes involved in fatty acid synthesis, but these pathways are not firmly established. Because most evidence comes from cell and animal models, whether the same effects occur in humans is an open question.

Notes from published material

=== 21 April === Russia claimed to have taken Bohdanivka, three kilometers from Chasiv Yar. The Russian-installed governor of Sevastopol said that a Neptune missile was launched at a vessel of the Russian Black Sea Fleet, causing a small fire. The Ukrainian Navy claimed that it struck the salvage ship Kommuna. Subsequent satellite images did not reveal any damage. Ukrainian military observer Kostyantyn Mashovets claimed that the Russian Central Grouping of Forces, which operates in the Pokrovsk and Toretsk directions (northwest and northeast of Avdiivka), had over 86,000 personnel, 280 tanks, 760 armored vehicles, and around 1,100 tube and rocket artillery systems.

Metal tagged antibodies however are viable for up to two weeks without losing signal, adding more flexibility to experiments. The stained samples can also be cryopreserved, which may be particularly useful for clinical trials when samples are collected over a longer period of time. Costs of CyTOF are high, as the metal-tagged antibodies and antibody conjunction kits are expensive. A major downside of CyTOF is that acquisition flow rate is quite slow compared to flow cytometry, by almost an order of magnitude. Because heavy metals are common in laboratory reagents, avoiding contamination during sample preparation is very important.

McKew said that "Putin and his minions have spent the past 15 years ranting about how the West (specifically NATO) wants a new Cold War". She suggested that "fighting a new Cold War would be in America's interest", adding "We won the last Cold War. We will win the next one too". The New Republic editor Jeet Heer criticised McKew's suggestion as "troubling" and for "wildly overstating the extent of Russian ambitions and power". Heer said that unlike the old Cold War, "Current U.S. troubles with Russia aren't the result of ideological differences ... and are intensely localized along Russia's borders, in countries like the Ukraine and Georgia". Jeremy Shapiro, a senior fellow in the Brookings Institution, wrote in his blog post at RealClearPolitics, referring to the US–Russia relations: "A drift into a new Cold War has seemed the inevitable result" of "Russian–Western confrontation" over Eastern European counties such as Ukraine, Moldova and Georgia. In August 2017, Russian Deputy Foreign Minister Sergei Ryabkov denied claims that the US and Russia were having another cold war, despite ongoing tensions between the two countries over Ukraine and Syria, and newer US sanctions against Russia. The University of East Anglia graduate student Oliver Steward, as well as the Casimir Pulaski Foundation senior fellow Stanisław Koziej, attributed the Russia's Zapad 2017 exercise in Belarus as part of the new Cold War between Russia and the West.

One Sunday Adam comes in to work, and Cory is smoking pot with friends and listening to loud music. One day Sarah is turned down for a raise by Cory, who suggests Sarah find work that she wants to do, so Sarah quits her internship. Another weekend Cory offers Adam an "edible" lollipop and explains his idea for the shoe company; Adam thinks he understands, but is unaware that he ingested cannabis until afterwards when Crosby notices it. One day Cory fires Eddie, the design manager (who is replaced by "Spyder", Cory's friend) without Adam's knowledge. Adam (after a night at the hospital because of Amber's accident) gets mad at Cory, and Cory later thinks Adam's not happy there, is hurt that Adam's not in agreement with him, and fires Adam. Gilliam T. Blount (Richard Dreyfuss) is a former Broadway producer who served in Vietnam, where Zeek saved his life. He helps Sarah with her play and produces it in season 2. Zoe DeHaven (Rosa Salazar) is the "coffee girl" who was carrying the baby that Julia and Joel planned to adopt. However, after the baby was born, she decided to keep him. Amy Ellis (Skyler Day) is Drew's girlfriend during parts of seasons 3 and 4, and stays at Drew's dorm room for several weeks when she does not want to return to Tufts in season 5. Dr. Joe Prestridge (D. B. Woodside), aka "Dr. Joe", is Jabbar's pediatrician who dates Jasmine in season 3. He asks her and Jabbar to move in with him, but she reconciles with and marries Crosby instead. Rachel (Alexandra Daddario) is Adam and Crosby's assistant at their recording studio, The Luncheonette during season 3.

In autoimmune hemolytic anemia, concentrations of HbA1 are undetectable. Administration of prednisolone will allow the HbA1 to be detected. The alternative fructosamine test may be used in these circumstances and it also reflects an average of blood glucose levels over the preceding 2 to 3 weeks. All the major institutions such as the International Expert Committee Report, drawn from the International Diabetes Federation, the European Association for the Study of Diabetes, and the American Diabetes Association, suggest the HbA1c level of 48 mmol/mol (6.5 DCCT %) as a diagnostic level. The Committee Report further states that, when HbA1c testing cannot be done, the fasting and glucose-tolerance tests should be done. Screening for diabetes during pregnancy continues to require fasting and glucose-tolerance measurements for gestational diabetes at 24 to 28 weeks gestation, although glycated hemoglobin may be used for screening at the first prenatal visit.

Sources: en.wikipedia.org

Background from the literature

== Hadamard transform time-of-flight mass spectrometry == Hadamard transform time-of flight mass spectrometry (HT-TOFMS) is a mode of mass analysis used to significantly increase the signal-to-noise ratio of a conventional TOFMS. Whereas traditional TOFMS analyzes one packet of ions at a time, waiting for the ions to reach the detector before introducing another ion packet, HT-TOFMS can simultaneously analyze several ion packets traveling in the flight tube. The ions packets are encoded by rapidly modulating the transmission of the ion beam, so that lighter (and thus faster) ions from all initially released packets of mass from a beam get ahead of heavier (and thus slower) ions. This process creates an overlap of many time-of-flight distributions convoluted in form of signals. The Hadamard transform algorithm is then used to carry out the deconvolution process which helps to produce a faster mass spectral storage rate than traditional TOFMS and other comparable mass separation instruments.

=== Breast cancer === In studies of breast cancer prevention, lasofoxifene showed a 79% reduction in breast cancer incidence and an 83% reduction specific incidence of estrogen receptor-positive breast cancers, which is significantly higher than reductions found with the related SERMs tamoxifen and raloxifene. In accordance, a network meta-analysis of SERMs for breast cancer prevention found the highest reduction in risk with lasofoxifene of all the drugs. The reduction was even greater than that observed with aromatase inhibitors, which have generally been found to confer a greater risk reduction than SERMs. It also has shown promise in ESR1 mutant patients with 'approximately 40% of patients harboring this mutation'.

The pancreas, located in the abdomen, below and behind the stomach, is both an exocrine and an endocrine gland. The alpha and beta cells are the endocrine cells in the pancreatic islets that release insulin and glucagon and smaller amounts of other hormones into the blood. Insulin and glucagon influence blood sugar levels. Glucagon is released when the blood glucose level is low and stimulates the liver to release glucose into the blood. Insulin increases the rate of glucose uptake and metabolism by most body cells. Somatostatin is released by delta cells and acts as an inhibitor of GH, insulin, and glucagon.

Myomeres are overlapping "cones" of muscle fibers bound by connective tissue. The shape of myomeres varies by species. Myomeres are commonly zig-zaged, being stacks or lines of muscle fibers shaped like "V" (lancelets), "W" (fishes), or straight (tetrapods). Generally, cyclostome myomeres are arranged in vertical strips while those of jawed fishes are folded in a complex manner due to their derived nature and evolution of advanced swimming capability. Specifically, myomeres of elasmobranchs and eels are W-shaped, while the myomeres of tetrapods, such as mudpuppies, run vertically and do not display complex folding. Myomeres overlap each other in succession, meaning myomere activation also allows neighboring myomeres to activate. They are innervated by spinal nerves, which pass into each myomere. Myomeres are made up of myoglobin-rich dark muscle as well as white muscle. Dark muscles generally function as slow-twitch muscle fibers while white muscle is composed of fast-twitch fibers. In gnathostomes, the myomeres are separated by myoseptal tendons. Specifically, these are the myorhabdoid tendons, the lateral tendons, the epineural tendon, and the epipleural tendon.

Aerobic conditioning Neurobiological effects of physical exercise - improves: Executive function Memory Stress management Physical fitness, including improving and maintaining these aspects of it: Accuracy Agility Balance Coordination Endurance Flexibility Power Speed Stamina Strength Prevention – exercise helps prevent: Cancer Drug addiction Hypertension Major depressive disorder Neurodegenerative disorders Obesity Osteoporosis Type 2 Diabetes

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 approved for medical use?

No major regulatory agency has approved AOD-9604 as a medicine. It is treated as an experimental peptide in research settings. Some countries restrict its sale or import.

Why is it banned in sports?

The World Anti-Doping Agency classifies growth hormone fragments, including AOD-9604, as prohibited substances. The classification reflects concern about potential performance-enhancing use. Athletes are subject to testing for such peptides.

How is AOD-9604 detected?

Detection typically uses liquid chromatography combined with mass spectrometry. These methods separate the peptide and identify it by mass. Immunoassays may screen samples but require confirmation by a more specific technique.

How is AOD-9604 typically analyzed?

Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.

Network